Nevertheless, data presented in this report provide evidence that ATRA treatment inhibited the growth of DU145 prostate cancer cells, through a mechanism that involved the upregulation of HOXB13 by reducing the methylation level at gene’s promoter. The gene discussed is HOXB13; the disease is prostate carcinoma.